Melatonin,
also known as melatonine, aprotinin, pineal gland, whose chemical name is
N-acetyl-5-methoxytryptamine, is a kind of amine hormone that mainly produced
by the mammalian and human pineal gland.
Lerner
(1959) was the first to isolate a kind of hormone in the pineal gland, named MELA because of its function of making cells that produce melanin glow. In addition,
because it is derived from serotonin ,he used its suffix -tonin.Thus, the
pineal hormone was called Melatonin. Melatonin is present in very small
amounts in the body at pg (1x10-12g) levels. In recent years,
extensive studies have been conducted on the biological functions of melatonin
at home and abroad, especially its health care function as a kind of dietary
supplement, indicating that it has many physiological functions such as
promoting sleep, regulating jet lag, anti-aging, regulating immunity and
anti-tumor, and is the first line of defense against oxidative stress.
In
terms of different applications, melatonin is mainly used as kind of dietary
supplement, medical medicine, and occasionally other uses. Melatonin as a kind
of dietary supplement accounts for more than half of the market. In 2020, the global
market share of melatonin supplements in different application segments of the
melatonin industry was 53.31%, while the share for medical use was 33.16%.
Melatonin
was once popular in some countries and regions, but the trend soon faded
because of the unclear function of melatonin.
Worldwide, except for a few countries and regions such as the United
States and Hong Kong, which regard melatonin as health food, most countries
(regions) such as Canada, the United Kingdom, France, Italy and Ireland hold a
cautious attitude towards the use of melatonin, strictly control it as a
prescription drug, and do not sell it freely in pharmacies.
According
to our research, the global market value of melatonin industry was﹩625.24 million in
2015 and grew to ﹩1086.39
million in 2019. However, due to the
impact of COVID-19, the total market value of the industry decreased to﹩1053.49 million in
2020. Based on this data, we carry out a series of functional operations, and
deduce the data of the next five years through scientific models. Finally, it
is predicted that the total global market of melatonin industry will reach﹩1942.96 billion by
2025, with a CAGR of 13.02% from 2020 to 2025.
Research
data show that North America is the largest revenue market. In 2015,
the market share of melatonin industry in North America was 45.80%. In 2020,
the market share in North America decreased slightly to 45.40%, while the
Market share in Europe ranked second with 28.67%.The continued economic
development in these regions, increased downstream demand, and continuous
technological innovation and progress will drive the growth of the melatonin
industry.
The global melatonin industry has a low market concentration. In 2020, Natrol of the United States took the first position in the industry with a market share of 1.69%. Natrol was founded in 1980 by Elliott Balbert as a cosmetics company. Over the past few decades, Natrol has developed into one of the best-known brands in the field of vitamins, minerals and supplements, helping to form what is now known as the Nutriceutical industry. Natrol is considered a pioneer in turning food into pharmaceutical supplements to improve health. Nature\'s Bounty from the United States and Jameison from Canada ranked second and third with market share of 1.12% and 0.98%, respectively. The total market share of the three companies is less than 5%, and the share of the top six companies in the industry is less than 10%. It is therefore self-evident that the industry is highly competitive.
Get the complete sample, please click: https://www.globalmarketmonitor.com/reports/762498-melatonin-market-report.html
As Sleep Problems Become More and More Serious, the Development of Global Melatonin Industry Has Become an Inevitable Trend
Melatonin
has become the fastest-growing component of immune balance products with its
dual function of helping sleep and enhancing immunity. The melatonin market is
growing rapidly as sleep problems increase around the world. In terms of market
size, it has been growing rapidly since 2015 and has reached﹩1053.49 million by
2020. Statistics show that more than 61%
adults worldwide suffer from sleep disorders, with most falling asleep after
11pm and some staying up until after 1am. In the first half of 2020, prolonged
stay at home due to the pandemic exacerbated the situation, with the survey
showing that while most people slept longer, people slept two to three hours
later overall, and searches for sleep problems also increased by 43%. In
addition, global sleep problems tend to be younger, and the development of
melatonin industry is inevitable.
However, as far as the overall market of sleep medicine and health care products is concerned, there are many kinds of products, and the market competition is becoming more and more white-hot. The market demand for melatonin is also growing, but the purity extraction rate of existing melatonin is low in the process of production, and the production cost is high. At present, many melatonin manufacturers are shifting from traditional melatonin production to technical application. As the technology matures, the market for high melatonin prices may be about to change.
Get the complete sample, please click: https://www.globalmarketmonitor.com/reports/762498-melatonin-market-report.html
We provide more professional and intelligent market reports to complement your business decisions.